Amy Sion to Neoplasms
This is a "connection" page, showing publications Amy Sion has written about Neoplasms.
Connection Strength
0.590
-
Evaluation of arthralgias in adult oncology patients receiving immune checkpoint inhibitors. J Oncol Pharm Pract. 2019 Dec; 25(8):1867-1872.
Score: 0.292
-
Lysyl oxidase (LOX) and hypoxia-induced metastases. Cancer Biol Ther. 2006 Aug; 5(8):909-11.
Score: 0.124
-
Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy. Semin Oncol. 2018 06; 45(3):156-163.
Score: 0.072
-
A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics. J Oncol Pharm Pract. 2019 Jun; 25(4):847-854.
Score: 0.069
-
CYP2D6 polymorphisms and the impact on tamoxifen therapy. J Pharm Sci. 2007 Sep; 96(9):2224-31.
Score: 0.033